Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion
Background: Linezolid has been found to have considerable interindividual variability, especially in critically ill patients, which can lead to suboptimal plasma concentration. To overcome this shortcoming, several solutions have been proposed. These include using loading dose, higher maintenance do...
Tallennettuna:
Päätekijät: | Ligia-Ancuța Hui (Tekijä), Constantin Bodolea (Tekijä), Adina Popa (Tekijä), Ana-Maria Vlase (Tekijä), Elisabeta Ioana Hirișcău (Tekijä), Laurian Vlase (Tekijä) |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
Tekijä: Ligia-Ancuta Hui, et al.
Julkaistu: (2022) -
Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
Tekijä: Ahmed E. Abou Warda, et al.
Julkaistu: (2022) -
Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
Tekijä: Susan E. Smith, et al.
Julkaistu: (2023) -
Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
Tekijä: Aalok V. Khole, et al.
Julkaistu: (2023) -
Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers
Tekijä: Ana-Maria Gheldiu, et al.
Julkaistu: (2017)